FIE Fielmann Group AG

XETRA · DE · Healthcare · Medical Instruments & Supplies · fielmann-group.com

37.60EUR+0.27%Mkt Cap: 3.42B $P/E: 15.12Today

Fielmann Group AG engages in vision care and audiology business in Germany, Switzerland, Austria, Spain, North America, and internationally. The company manufactures and sells visual aids mainly glasses, eyewear frames a…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc. - Common Stock

$140.43BUSDP/E 44.8

EssilorLuxottica Societe anonyme

$71.20BUSDP/E 26.7

BDX

Becton, Dickinson and Company Common Stock

$48.16BUSDP/E 30.5

MDLN

Medline Inc. - Class A common stock

$47.91BUSDP/E 44.5

RMD

ResMed Inc. Common Stock

Alcon Inc. Ordinary Shares

$30.82BUSDP/E 48.7

WST

West Pharmaceutical Services, Inc. Common Stock

$25.69BUSDP/E 46.8

DIM

Sartorius Stedim Biotech

$22.02BUSDP/E 69.2

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.20BUSDP/E 71.6

SOLV

Solventum Corporation Common Stock

$14.95BUSDP/E 10.7

BAX

Baxter International Inc. Common Stock

$12.14BUSD

COO

The Cooper Companies, Inc. - Common Stock

$10.82BUSDP/E 19.6

AVTR

Avantor, Inc. Common Stock

$10.38BUSD

COO

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

RGEN

Repligen Corporation - Common Stock

$10.25BUSDP/E 248.9

ALGN

Align Technology, Inc. - Common Stock

$10.21BUSDP/E 25.0

ATR

AptarGroup, Inc. Common Stock

$7.62BUSDP/E 21.6

Key Statistics

Company

Market Cap3.42B USD

Enterprise Value4.09B USD

Revenue (TTM)2.67B USD

Gross Profit2.12B USD

Net Income (TTM)221.45M USD

Revenue/Share29.29 EUR

Last Price37.60 EUR

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees18.2K

CountryDE

SectorHealthcare

IndustryMedical Instruments & Supplies

ISINDE0005772206

Valuation

P/E (Trailing)15.12

P/E (Forward)13.42

PEG3.20

EV/EBITDA8.56

EV/Revenue1.53

P/S1.28

P/B2.85

EPS (TTM)2.53

EPS (Forward)2.79

52W Range

36.656% of range51.40

52W High51.40 EUR

52W Low36.65 EUR

Profitability

Gross Margin79.94%

Oper. Margin13.89%

EBITDA Margin17.88%

Profit Margin8.37%

ROE20.75%

ROA8.20%

Growth

Revenue Growth2.30%

Earnings Growth6.30%

Cash Flow & Leverage

Operating CF539.12M USD

CapEx (TTM)125.86M USD

FCF Margin10.51%

FCF Yield8.21%

Net Debt679.52M USD

Net Debt/EBITDA1.42

Balance Sheet

Debt/Equity0.90

Current Ratio1.35

Quick Ratio0.86

Book Value/Sh13.17 EUR

Cash/Share3.23 EUR

Dividends

Fwd Div Rate1.40 EUR

Trail. Div Rate1.40 EUR

Div. Yield3.73%

5Y Avg Yield2.37%

Payout Ratio45.45%

Ex-Div DateJul 10, 2026

Pay Date—

Splits

Last Split2:1

Split DateAug 22, 2014

Analyst Consensus

Rating—

Target (Mean)55.25 EUR

Upside (mean)+46.9%

Target Range46.00 EUR – 64.00 EUR

46.00+46.9% to mean64.00

# Analysts8

Ownership

Shares Out.83.96M

Float22.55M

Insiders72.91%

Institutions10.44%

Technical

SMA 5039.50 (-4.8%)

SMA 20042.23 (-11.0%)

Beta0.61

S&P 52W Chg14.58%

Avg Vol (30d)69.24K

Avg Vol (10d)55.07K

Technical Indicators

RSI (14)40.6

MACD-0.4553

MACD Signal-0.5654

MACD Hist.+0.1101

BB Upper39.34 EUR

BB Middle38.03 EUR

BB Lower36.72 EUR

BB Width6.90%

ATR (14)0.7363 EUR

Vol Ratio (20d)0.48x